Login / Signup

CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancer.

Francesco MontorsiMarco MoschiniAndrea Necchi
Published in: BJU international (2020)
Keyphrases
  • phase ii
  • muscle invasive bladder cancer
  • open label
  • phase iii
  • clinical trial
  • placebo controlled
  • double blind
  • study protocol
  • randomized controlled trial